Harlingen Physicians Performed Rare Brain Procedure
A medical team in Harlingen utilized a specialized embolic agent to successfully treat a subdural hematoma on August 21, 2026.
Updated on Oct. 12, 2026 in Stroke

Physicians at Valley Baptist Medical Center successfully performed a bilateral Onyx 12 middle meningeal artery (MMA) embolization on August 21, 2026. This procedure was used to treat a subdural hematoma in an elderly patient.
Why it matters
This procedure uses a low-viscosity liquid agent to block blood vessels that feed into a hematoma. By stopping blood flow to these specific vessels, doctors can address the injury more effectively than with previous methods.
The procedure involved the first-ever documented use of a lower-viscosity liquid embolic agent to treat a subdural hematoma. The intervention targeted blood flow within the middle meningeal artery.
The players
Valley Baptist Medical Center
This hospital provides neurological care and advanced medical services to residents throughout the Rio Grande Valley region.
The details
The medical team performed the bilateral embolization by injecting the Onyx 12 agent directly into vessels contributing to the patient injury. The specialized lower-viscosity formulation allowed for more precise flow compared to conventional techniques.
Timeline
The bilateral Onyx 12 MMA embolization took place on August 21, 2026.
Health Landscape
This procedure represents an advancement in neuro-interventional techniques by utilizing a lower-viscosity agent not previously employed in this specific application. It builds upon the development of standard MMA embolization techniques used to treat intracranial issues.
This specialized treatment offers an additional option for elderly patients suffering from complex subdural hematomas. Patients and families should consult with their neurosurgical team to determine if such targeted embolization is appropriate for their specific case.
The takeaway
The use of advanced embolic agents demonstrates how precise, minimally invasive techniques continue to evolve for elderly populations. This method highlights the importance of targeted interventions in managing chronic or acute intracranial bleeding.
Further reading
For more information on the latest neurological interventions, visit Stroke.










